Prospective phase II study on low dose 5-Azacitidine for treatment of symptomatic patients with low/intermediate-1 myelodisplasia.
Abstract
Publication Date:
2012
CRIS type:
4.2 Abstract in Atti di convegno
List of contributors:
Filì, C; Follo, M; Iacobucci, I; Cattina, F; Skert, C; Bergonzi, C; Malagola, Michele; Finelli, C; Gobbi, M; Candoni, A; Lauria, F; Lanza, F; Turra, A; Ribolla, R; Cancelli, V; Cocco, L; Russo, Domenico
Book title:
17th Congress of the European Hematology Association
Published in: